CECentral.com

(1 of 5) Adv.


(1 of 5) Adv.

Elliott M. Antman, MD, FACC
Elliott M. Antman, MD, FACC Dr. Antman is director of the Samuel A. Levine Cardiac Unit in the Cardiovascular Division of the Brigham and Women's Hospital in Boston, Massachusetts. Read More
Arthur Kavanaugh, MD
Arthur Kavanaugh, MD Dr. Kavanaugh is Professor of Medicine at The University of California at San Diego, School of Medicine and the Director of the Center for Innovative Therapy in Division of Rheumatology, Allergy and Immunology. Read More
Lawrence Rice, MD
Lawrence Rice, MD Dr. Lawrence Rice is Professor of Medicine in Hematology and Thrombosis Research. He has been Program Director of Hematology... Read More
Hatim Omar, MD, FAAP
Hatim Omar, MD, FAAP Dr. Omar is a Professor in Pediatrics and Obstetrics Gynecology and Director of Adolescent Medicine and Young Parent Program at the University of Kentucky in Lexington, Kentucky. Read More

Pharmacist Counter-Terrorism Preparedness Module 1: Viral Agents

1.00CPE
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better prepared to fully participate in these efforts. All healthcare systems, including both the public and private...  Read More

This activity presented by...

Craig Martin, PharmD, BCPS Clinical Pharmacy Specialist in Infectious Diseases
University of Kentucky Medical Center,...
Craig Martin, PharmD, BCPS

Future Opportunities in Pharmacy Practice-HIPAA/Privacy Rules: Practice and Research

1.00CPE
Research is moving from the hospitals into the communities at a growing pace. Investigational drugs are administered in ambulatory settings and even in emergency situations outside of the hospital setting. Pharmacists remain the “drug expert” resource for their patients and understanding how these types of research activities affect their lives is an important and evolving component of pharmaceutical care. The more informed we are as a profession about how research works in the...  Read More

This activity presented by...

Jimmi Hatton Kolpek, PharmD, SCCP, SCCM, BCNSP, CCRC Interim Chair, Pharmacy Practice and Science Department
Associate Professor, Pharmacy Practice...
Jimmi Hatton Kolpek, PharmD, SCCP, SCCM, BCNSP, CCRC

Pathology and Treatment of Rheumatoid Arthritis: Systematic Inflammation and Cardiovascular Risk: Relevance to Rheumatoid Arthritis

0.50CME
0.50CPE
0.50CNE

Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered appropriate therapeutic aims. Although they can be effective, up to half of patients treated with TNF inhibitors may...  Read More

This activity presented by...

Paul M. Ridker, MD, MPH, FACC, FAHA Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for...
Paul M Ridker, MD, MPH, FACC, FAHA

Pharmacist Counter-Terrorism Preparedness Module 2: Focusing on Potential Bacterial Weapons

1.00CPE
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better prepared to fully participate in these efforts. All healthcare systems, including both the public and private...  Read More

This activity presented by...

Robert P. Rapp, PharmD, FCCP Associate Director of Pharmacy Services
Clinical Pharmacy Specialist for Infectious Diseases ...
Robert P Rapp, PharmD, FCCP

Pharmacist Counter-Terrorism Preparedness Module 3: Organophosphates and Nerve Agents

1.00CPE
Since most experts predict there will be bioterrorism attacks and they may in fact come sooner rather than later, the United States Health Care System must be prepared to care for patients who are both injured but to also care for citizens in the locality who have been exposed to various agents of bioterrorism. This program is designed to help individual clinicians to be better prepared to fully participate in these efforts. All healthcare systems, including both the public and private...  Read More

This activity presented by...

Craig Martin, PharmD, BCPS Clinical Pharmacy Specialist in Infectious Diseases
University of Kentucky Medical Center,...
Craig Martin, PharmD, BCPS

Roundtable #3: Antimicrobial Resistance: Clinical Countermeasures

1.00CME
1.20CPE

Drug resistant organisms have increased across the globe and represent a major threat to the health of hospitalized patients. Overuse and improper use of certain antibiotic drug classes as well as failure to take infection control measures in hospitals has led to a major nosocomial infection problem in the United States. Antimicrobials account for upwards of 30% of hospital pharmacy budgets. It has been recognized for several decades that up to 50% of antimicrobial use is inappropriate,...  Read More

This activity presented by...

American Transplant Congress (ATC) Summary Monograph

1.00CME
1.20CPE
1.00CNE
The trend to minimize the use of calcineurin inhibitors (CNIs) and corticosteroids (CSs) has contributed to an increase in the use of antibody induction therapy in kidney and liver transplantation. Significant comorbid conditions associated with historical maintenance immunosuppressive regimens consisting of CNIs and CSs have resulted in a paradigm shift in clinical practice. Identification of immunosuppressive regimens that both reduce long-term immunosuppressive load, and minimize...  Read More

This activity presented by...

The Basics of Transplant Care: Tips, Tricks and Clinical Pearls

1.00CPE
Transplantation is a unique therapeutic option for patients with end organ disease. The pharmacotherapy involved in the treatment of the transplant patient is often challenging. Immunosuppressive agents used have narrow therapeutic indices and have the potential for long term toxicity. More and more patients are transplanted every year. Community pharmacists will encounter this patient population at some point in their career. This program is designed to educate pharmacists on some of the...  Read More

This activity presented by...

Timothy Clifford, PharmD Clinical Pharmacy Specialist, Transplant/Critical Care
University of Kentucky Medical Center,...
Timothy Clifford, PharmD

Roundtable #2: Collateral Damage Associated With Antimicrobial Use

1.00CME
1.20CPE

Drug resistant organisms have increased across the globe and represent a major threat to the health of hospitalized patients. Overuse and improper use of certain antibiotic drug classes as well as failure to take infection control measures in hospitals has led to a major nosocomial infection problem in the United States. Antimicrobials account for upwards of 30% of hospital pharmacy budgets. It has been recognized for several decades that up to 50% of antimicrobial use is inappropriate,...  Read More

This activity presented by...

A Dangerous Crystal: Understanding the Allure of Meth

1.00CPE

Methamphetamine is second only to cannabis in terms of worldwide drug abuse.  The drug is inexpensive, relatively easy to manufacture and is highly addictive.  Methamphetamine is most often produced in clandestine laboratories found in the Midwest and South.  Manufacture most commonly employs pseudoephedrine as a chemical precursor with the addition of various other chemicals which may include red phosphorus, lithium, ammonia, and sodium hydroxide.  The clinical effects...  Read More

This activity presented by...

Frank Romanelli, PharmD, MPH, BCPS Assistant Dean for Education / Associate Professor of Pharmacy
University of Kentucky College of...
Frank Romanelli, PharmD, MPH, BCPS

Roundtable #1: Antimicrobial Resistance: A Historical Perspective On A Current Threat

1.00CME
1.20CPE

Drug resistant organisms have increased across the globe and represent a major threat to the health of hospitalized patients. Overuse and improper use of certain antibiotic drug classes as well as failure to take infection control measures in hospitals has led to a major nosocomial infection problem in the United States. Antimicrobials account for upwards of 30% of hospital pharmacy budgets. It has been recognized for several decades that up to 50% of antimicrobial use is inappropriate,...  Read More

This activity presented by...

Asthma in Childhood: An Overview and Update

1.50CME
1.50CPE
Asthma is the leading serious chronic illness of children in the U.S.  In 2005, an estimated 6.5 million children under age 18 (almost 1.4 million under age 5) currently had asthma, 3.8 million of which had an asthma attack, and many others have "hidden" or undiagnosed asthma.

In 2005, the highest current prevalence rate was seen in those 5-17 years of age (97.2 per 1,000 population), with rates decreasing with age. Overall, the rate in those under 18 (89.0 per...  Read More

This activity presented by...

View All Meetings

© 2008 University of Kentucky, Colleges of Pharmacy & Medicine
Privacy Statement · Feedback · About CECentral.com